Cortexyme

Home » Cortexyme

IPO

Cortexyme

We are a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what we believe to be a key underlying cause of Alzheimer’s and other degenerative diseases.

Symbol

CRTX

Price Range
$16.00 - $18.00

Final Shares
4,400,000

Effective Date
May 9, 2019

Underwriters
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED, CREDIT SUISSE SECURITIES (USA) LLC

To view the prospectus for Cortexyme IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253